Key Messages Q3 Roadshow Season

Portfolio delivering resilience in challenging environment

Strategy execution well on track

  • ▪ Acquisition of Porocel

  • ▪ Announced Baby Care carveout

  • ▪ Asset optimization in Methionine

Sustainability as key driver in innovation

  • ▪ Next generation of ready-to-use PA12 powders for 3D printing - 80% reusability

  • ▪ Biosurfactants: Evonik as key pillar in Unilever's "Clean future" initiative

Portfolio has proven resilience YTD

  • ▪ Robust performance driven by growth divisions with only -1% yoy and stable pricing

  • ▪ Many businesses virtually unaffected by the crisis

"Promise and deliver" - EBITDA outlook confirmed & FCF outlook increased

  • ▪ EBITDA outlook now narrowed:

    Range of €1.8 bn to €2.0 bn

  • ▪ FCF upgraded once more:

    FCF ~€700 m and CCR >35%

Table of contents

1. Evonik at a glance

  • 2. Strategy

  • 3. Financials Q3 2020

  • 4. Appendix

LEADING BEYOND CHEMISTRY

TO IMPROVE LIFE, TODAY AND TOMORROW

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

Disclaimer

Evonik Industries AG published this content on 24 November 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 December 2020 17:08:03 UTC